Showing 117 of 117on this page. Filters & sort apply to loaded results; URL updates for sharing.117 of 117 on this page
Tepotinib | EMD-1214063 | 特泊替尼 | c-MET 抑制剂 | 抗肿瘤 | TargetMol
Predicted metabolic sites for tepotinib (TEP) by WhichP450™ module of ...
Tepotinib in patients with non-small cell lung cancer with high-level ...
Tepotinib Takes Aim at Novel MET Mutation in Lung Cancer Trial
Tepotinib cancer drug molecule. Skeletal formula Stock Vector Image ...
PP01.84 Tepotinib + Osimertinib in EGFR-mutant NSCLC with MET ...
An LC–MS/MS Analytical Method for Quantifying Tepotinib in Human Liver ...
Tepotinib Tepmetko 225mg Tablet 60 Tablets at ₹ 23500/box | Jagatpur ...
Tepotinib Receives Accelerated Approval for Metastatic NSCLC ...
Tepotinib Tablet - Tepmetko Tablet Latest Price, Manufacturers & Suppliers
Tepotinib 225 Mg Tepmetko Tablets (Pack of 30) at ₹ 152795/box in Surat ...
Tepotinib 225mg tablet at ₹ 152829/bottle | Tepotinib Tablet in ...
DailyMed - TEPMETKO- tepotinib hydrochloride tablet
Tepotinib – Application in Therapy and Current Clinical Research
Study on the Effectiveness of Tepotinib and Drug Combination for ...
Tepmetko Tepotinib 225mg Tablet at ₹ 150000/box | ANTICANCER TABLET-3 ...
Study of Tepotinib and Osimertinib for Patients with Advanced or ...
Tepotinib molecule flat skeletal structure, Tyrosine kinase - ALK, ROS1 ...
Tepotinib Gains Full Approval for Metastatic NSCLC | MedPage Today
Tepotinib Tepmetko 225mg Tablet 60 Tablets at ₹ 136500/strip ...
Tepotinib vs Capmatinib in NSCLC | PDF | Biochemistry | Chemistry
Tepotinib 225 mg Tablets at ₹ 142020/box | Tepmetko Tablet in Nagpur ...
TEPMETKO (tepotinib) FDA Where is tepotinib approved? [VIDEO ...
Tepotinib and Gefitinib in NSCLC Study | PDF | Epidermal Growth Factor ...
PP01.83 Treatment Sequencing in the VISION Study of Tepotinib in ...
TEPMETKO 225MG Tepotinib Tablets By Merck at ₹ 145000/box | Anti Cancer ...
Brain penetration and efficacy of tepotinib in orthotopic patient ...
Pharmacokinetics of tepotinib at day 20 of the treatment. (A) Tepotinib ...
tepotinib molecule, molecular structures, antineoplastic agents, 3d ...
The patient's clinical course before and after the tepotinib treatment ...
Tepotinib 225mg tablet at Rs 152829 | in Vadodara | ID: 2854862407948
Luci-Tepo 225mg Tepotinib Tablet, Non-Small Cell Lung Cancer, 60 ...
Study of Tepotinib for Patients with Advanced Lung Cancer with MET Exon ...
Tepmetko 225mg Tablet Tepotinib 225mg at ₹ 152829/box | Tepotinib ...
(PDF) Tepotinib hydrochloride for the treatment of non-small cell lung ...
Tepotinib Treatment in Patients With MET Exon 14–Skipping Non–Small ...
Tepotinib - Anwendung, Wirkung, Nebenwirkungen | Gelbe Liste
PharmaWiki - Tepotinib
Các thông tin cơ bản về hoạt chất Tepotinib điều trị ung thư
Tepotinib Tepmetko 225mg Tablet 60 Tablets at Rs 25000 | Jagatpur ...
Tepotinib and Tepotinib + Osimertinib for Brain Tumor Clinical Trial ...
Real world outcomes with Tepotinib in a series of Indian patients with ...
Tepotinib in Asian patients with METex14 skipping NSCLC | Research ...
Exceptional sustained long-term complete response to Tepotinib in a MET ...
Thuốc Tepotinib điều trị ung thư phổi không tế bào nhỏ đột biến MET-ex14
Activity of Tepotinib in Hepatocellular Carcinoma With High-Level MET ...
(PDF) Randomized Trial of Tepotinib Plus Gefitinib versus Chemotherapy ...
Clinical course of oral administration of tepotinib and capmatinib, the ...
Tepotinib granted FDA priority review for METex14 NSCLC | BLU Ampersand ...
Expert Commentary on the Product Profile of Tepotinib
Mechanisms of action of tepotinib as a tyrosine kinase inhibitor. (A ...
Tepotinib plus osimertinib in patients with EGFR-mutated non-small-cell ...
The combination of targeted therapies with tepotinib or TNO155 ...
Tepotinib overcomes MET-mediated sotorasib resistance in vivo Antitumor ...
Tepotinib in a Patient With Advanced Non-Small Cell Lung Cancer ...
First-in-Man Phase I Trial of the Selective MET Inhibitor Tepotinib in ...
Mean plasma concentration–time curve for tepotinib and total ...
Workflow of model development. The effects of tepotinib and ...
How is Tepotinib Synthesised?_Chemicalbook
First-line use of tepotinib in METex14 NSCLC: A patient-centered ...
Tepotinib inhibits proliferation, migration and invasion of melanoma ...
Modelling the Effectiveness of Tepotinib in Comparison to Standard-of ...
The FDA has approved tepotinib for patients with metastatic non-small ...
Synthesis, Evaluation, and Mechanism Study of New Tepotinib Derivatives ...
Tepotinib Synthesis - YouTube
Figure 2 from Successful and Prompt Treatment with Tepotinib for Lung ...
Table 1 from Randomized Trial of Tepotinib Plus Gefitinib versus ...
A phase II study of tepotinib in patients with advanced solid cancers ...
Pseudo-acute kidney injury secondary to tepotinib - PMC
(PDF) Phase I trial of the MET inhibitor tepotinib in Japanese patients ...
Identification of Iminium Intermediates Generation in the Metabolism of ...
Tepotinib’s approved recently got upgraded from accelerated to ...
Tolerability and Activity of Second-Line Tepotinib, a Potent and Highly ...
Hematology / Oncology-TLPH – Tongmeng (Lao) Pharmaceutical & Food Co., Ltd.
Tepmetko (tepotinib) reimbursed in Ireland for patients with advanced ...
居民医保断交可以办理灵活就业 - 特泊替尼 - 必需药
城乡居民医保断缴会如何 - 特泊替尼 - 必需药
居民医保断了怎么办理 - 特泊替尼 - 必需药
居民医保断交会影响退休吗 - 特泊替尼 - 必需药
城乡居民医保断交一年 - 特泊替尼 - 必需药
农村医保断交之前的就白交了吗 - 特泊替尼 - 必需药
Thuốc Tepmetko (Tepotinib Hydrochloride) mua ở đâu?
Biophysical and structural characterization of the impacts of MET ...
Thuốc Tepotinib: Công dụng, chỉ định và lưu ý khi dùng
Home — DrugsHK
Table 1 from Development and Validation of Liquid Chromatography Method ...
Tepotinib: A New Precision Therapy Breakthrough for Non-Small Cell Lung ...
一文了解靶向药特泊替尼（Tepotinib/Tepmetko）说明书-老挝仿制药-价格-上市进度 - 知乎
TEPMETKO (tepotinib) resources for patients
国内第4款MET抑制剂：德国默克盐酸特泊替尼（Tepotinib）获批上市了 - 知乎
(PDF) The Preclinical Pharmacology of Tepotinib—A Highly Selective MET ...
(PDF) Population pharmacokinetic analysis of tepotinib, an oral MET ...
【特泊替尼,拓得康,Tepotinib,Tepmetko,LuciTepo】说明书_代购价格_印度直邮-印度全球药房
2021年2月，FDA批准的8款新藥 - 每日頭條
默克靶向抗癌药tepotinib治疗携带METex14跳跃改变的非小细胞肺癌（NSCLC）患者！-上市-医保-临床适应症-香港济民药业
Synergistic prolongation of survival by irradiation and... | Download ...
00270-5/asset/d2076fba-f792-4293-9922-dc78afb1920d/main.assets/gr1_lrg.jpg)
00270-5/asset/59a13b80-2dac-41af-8227-b7cc8ec85081/main.assets/gr3a.jpg)
